
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories Inc. has reported a year-over-year increase of 1.6% in its product and services revenue, surpassing company forecasts due to favorable deal timing. The company's diversified revenue growth, particularly in the Other category driven by innovations like AtmosAuto and Dolby Cinema, positions it for further expansion, especially with nearly half of total licensing revenues coming from these areas. Additionally, Dolby's strategic initiatives, including SaaS-like models for patent licensing and the OptiView solution, are anticipated to enhance revenue streams, reinforcing a positive outlook for the company's financial performance.
Bears say
Dolby Laboratories Inc. is projected to experience a decline in revenue, with expectations of a 7.5% year-over-year decrease in License Revenue and a 5.7% drop in Products and Services for the December quarter. Additionally, gross margins have decreased to 89.8% from 90.8% due to lower margins in Product/Services, further exacerbated by a forecasted high-single-digit revenue decline for fiscal 2026, mirroring the trends observed in fiscal 2025. The company faces challenges in the PC and consumer electronics markets, which are expected to contribute to overall weakening revenue prospects, alongside modestly lower licensing revenues and difficult year-over-year comparisons in the upcoming quarter.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares